Companies Like Bonus BioGroup (TLV:BONS) Are In A Position To Invest In Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Israeli (TA) Biotech Industry Analysis
UpdatedJun 30, 2022
DataAggregated Company Financials
Companies16
- 7D-0.6%
- 3M-24.7%
- 1Y-54.8%
- YTD-45.3%
Over the last 7 days, the Biotech industry has remained flat, although notably Can-Fite BioPharma gained 14%. As for the longer term, the industry has declined 55% in the last year. Looking forward, earnings are forecast to grow by 55% annually.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Fri, 01 Jul 2022 | ₪2.1b | ₪494.4m | -₪401,552,695.00 | 12.6x |
| Sun, 29 May 2022 | ₪2.2b | ₪482.7m | -₪435,253,162.00 | 13.8x |
| Tue, 26 Apr 2022 | ₪2.8b | ₪466.4m | -₪499,790,987.00 | 14x |
| Thu, 24 Mar 2022 | ₪2.8b | ₪459.0m | -₪216,239,616.00 | 3.4x |
| Sat, 19 Feb 2022 | ₪2.9b | ₪457.8m | -₪220,956,082.00 | 7.1x |
| Mon, 17 Jan 2022 | ₪3.6b | ₪447.6m | -₪213,865,355.00 | 6.7x |
| Wed, 15 Dec 2021 | ₪3.5b | ₪436.9m | -₪213,453,475.00 | 9x |
| Fri, 12 Nov 2021 | ₪3.9b | ₪462.7m | -₪167,516,669.00 | 10x |
| Sun, 10 Oct 2021 | ₪4.1b | ₪476.0m | -₪174,362,856.00 | 10.3x |
| Tue, 07 Sep 2021 | ₪4.4b | ₪479.4m | -₪177,420,697.10 | 7.2x |
| Thu, 05 Aug 2021 | ₪4.0b | ₪483.2m | -₪167,305,098.00 | 4.7x |
| Sun, 09 May 2021 | ₪4.2b | ₪528.7m | -₪109,530,611.00 | 3.6x |
| Wed, 10 Feb 2021 | ₪4.3b | ₪520.8m | -₪60,037,930.40 | 2.8x |
| Tue, 03 Nov 2020 | ₪2.7b | ₪546.7m | -₪199,116,926.70 | 9.9x |
| Fri, 07 Aug 2020 | ₪2.4b | ₪541.9m | -₪227,418,479.00 | 10.9x |
| Thu, 30 Apr 2020 | ₪2.2b | ₪616.6m | -₪322,626,634.70 | 121x |
| Sun, 02 Feb 2020 | ₪1.6b | ₪563.9m | -₪314,626,521.20 | 17.3x |
| Wed, 06 Nov 2019 | ₪1.5b | ₪609.2m | -₪219,539,279.00 | 17.5x |
| Sat, 10 Aug 2019 | ₪1.7b | ₪548.7m | -₪236,195,260.90 | 26.6x |
Median PE Ratio
25.9x
Current Industry PE
- Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
- The industry's 3-year average PS ratio 5.5x is higher than the industry's current PS ratio of 4.3x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Revenues have also declined 3.4% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does Israeli Biotech compare with similar industries?
| IL Market | 1.61% | |
| Healthcare | 0.90% | |
| Biotech | -0.62% | |
| Biotech | -0.62% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| KMDA Kamada | ₪15.89 | 3.7% +₪25.1m | -16.2% | PS1.9x | |
| CANF Can-Fite BioPharma | ₪0.11 | 6.0% +₪4.9m | -56.9% | PS27.3x | |
| NXTG Nextage Therapeutics | ₪1.22 | 8.4% +₪2.6m | -74.6% | PS374.8x | |
| XTLB XTL Biopharmaceuticals | ₪0.054 | 3.8% +₪1.1m | -58.8% | PE12.9x |